Driehaus Capital Management LLC Relay Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

$9.27 Billion
Q2 2024

A detailed history of Driehaus Capital Management LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 616,220 shares of RLAY stock, worth $4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

616,220

Previous 616,220 -0.0%

Holding current value

$4 Million

Previous $4.02 Million -0.0%

% of portfolio

0.04%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $1.29 Million - $1.75 Million	218,302 Added 54.86%	616,220 $4.02 Million
Q1 2024 May 15, 2024	SELL	$7.5 - $12.07 $1.46 Million - $2.35 Million	-195,084 Reduced 32.9%	397,918 $3.3 Million
Q2 2023 Aug 14, 2023	SELL	$9.99 - $18.27 $9.88 Million - $18.1 Million	-989,249 Reduced 62.52%	593,002 $7.45 Million
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $541,530 - $821,681	-36,102 Reduced 2.23%	1,582,251 $26.1 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $19.1 Million - $32.4 Million	-1,349,092 Reduced 45.46%	1,618,353 $24.2 Million
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $2.26 Million - $3.93 Million	-125,281 Reduced 4.05%	2,967,445 $66.4 Million
Q2 2022 Aug 15, 2022	SELL	$13.31 - $34.88 $12.8 Million - $33.4 Million	-957,962 Reduced 23.65%	3,092,726 $51.8 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $330,886 - $528,503	16,332 Added 0.4%	4,050,688 $121 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $25.6 Million - $36.4 Million	983,654 Added 32.24%	4,034,356 $124 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $5.85 Million - $7.47 Million	196,662 Added 6.89%	3,050,702 $96.2 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $8.56 Million - $11.9 Million	311,421 Added 12.25%	2,854,040 $104 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $47 Million - $89 Million	1,446,339 Added 131.93%	2,542,619 $87.9 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $826,353 - $1.26 Million	23,271 Added 2.17%	1,096,280 $45.6 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $35.2 Million - $48.4 Million	1,073,009 New	1,073,009 $45.7 Million

Others Institutions Holding RLAY

# of Institutions

183

Shares Held

127M

Call Options Held

1.7K

Put Options Held

18K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $780M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Relay Therapeutics, Inc. Transaction History